Transient receptor potential vanilloid-1 antagonist AMG517 playing a neuroprotective role in cerebral ischemia/reperfusion injury in mice by regulating the release of inflammatory factors

PENG Zhi-Feng

doi:10.16098/j.issn.0529-1356.2020.02.003

PDF(1605 KB)

Acta Anatomica Sinica ›› 2020, Vol. 51 ›› Issue (2) : 167-171. DOI: 10.16098/j.issn.0529-1356.2020.02.003

Transient receptor potential vanilloid-1 antagonist AMG517 playing a neuroprotective role in cerebral ischemia/reperfusion injury in mice by regulating the release of inflammatory factors

PENG Zhi-feng^1* LIU Ying¹ NIU Chun-hong²

Author information +

History +

Abstract

Objective To investigate the effects of transient receptor potential vanilloid-1(TRPV1) antagonist AMG517 on cerebral ischemic/reperfusion injury in mice. Methods Forty male C57BL/6 mice were assigned to the following groups: sham group, vehicle+ischemia/reperfusion group (vehicle), capsaicin+ischemia/reperfusion group(capsaicin), and AMG517+ischemia/reperfusion group(AMG517). Ischemic/reperfusion injury was induced by permanent middle cerebral artery occlusion(MCAO) and neurological deficits were evaluated 72 hours after MCAO. Then, infarct volume, brain edema, mRNA expression of TRPV1 and serum concentrations of tumor necrosis factor α(TNF-α) and interleukin-10 (IL-10) were measured. Results Compared with the vehicle group, AMG517 significantly decreased the infarct volume (P<0.01). Neurobehavioral score significantly decreased following administration of AMG517 (P<0.01) 72 hours after MCAO. Compared with the sham group, the mRNA expression of TRPV1 significantly increased in vehicle group (P<0.01). AMG517 significantly increased the anti-inflammatory cytokine IL-10 and decreased the inflammatory cytokine TNF-α (P<0.05). Conclusion AMG517 can improve ischemia/reperfusion injury in mice and may play a neuroprotective effect by alleviating inflammation.

Key words

Ischemia/reperfusion injury / Transient receptor potential vanilloid-1 / AMG517 / Neurobehavioral score / Real-time PCR / Enzyme inked immunosorbent assay / Mouse

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

PENG Zhi-feng LIU Ying NIU Chun-hong. Transient receptor potential vanilloid-1 antagonist AMG517 playing a neuroprotective role in cerebral ischemia/reperfusion injury in mice by regulating the release of inflammatory factors[J]. Acta Anatomica Sinica. 2020, 51(2): 167-171 https://doi.org/10.16098/j.issn.0529-1356.2020.02.003

References

［1］ Peng ZhF. Effect of microＲNA-181b on ischemic stroke by regulating the heat shock protein A5 in mice［J］. Acta Anatomica Sinica, 2017, 48(1):25-29.(in Chinese)

彭志锋. 微小RNA-181b通过调节热休克蛋白A5在缺血性脑卒中小鼠中的作用［J］. 解剖学报, 2017,48(1):25-29.

［2］ Pétrault M, Gautier S, Bérézowski V, et al. Neither nefopam nor acetaminophen can be used as postoperative analgesics in a rat model of ischemic stroke［J］. Fundam Clin Pharmacol, 2016, 30(10):12246.

［3］ Ouk T, Potey C, Laprais M, et al. PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental stroke.［J］. Fundam Clin Pharmacol, 2014, 28(3):294-302.

［4］ Li L, Wu ShZh, Zhang ShK. Advances in immunology after ischemic stroke［J］. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 2015, 17(2):219-221. (in Chinese)

李立, 吴世政, 张淑坤. 缺血性脑卒中后相关免疫学研究进展［J］. 中华老年心脑血管病杂志, 2015, 17(2):219-221.

［5］ Wang J. The expression pattern of TRPV1 in brainChinese ［J］. Journal of Neuroanatomy, 2011, 27(6):709-710. (in Chinese)

王舰. TRPV1在脑的表达模式［J］. 神经解剖学杂志, 2011, 27(6):709-710.

［6］ Zielińska M, Jarmu z· A, Wasilewski A, et al. Role of transient receptor potential channels in intestinal inflammation and visceral pain: novel targets in inflammatory bowel diseases ［J］. Inflamm Bowel Dis, 2015, 21(2):419-427.

［7］ Miyanohara J, Shirakawa H, Sanpei K, et al. A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice［J］. Biochem Biophys Res Commun, 2015, 467(3):478-483.

［8］ Rodriguez R, Santiago-Mejia J, Gomez C, et al. A simplified procedure for the quantitative measurement of neurological deficits after forebrain ischemia in mice［J］. J Neurosci Methods, 2005, 147(1):22-28.

［9］ Xie YW, Zhang F, Guo Y. Correlation between cerebral blood flow and infart volume of the middle cerebral artery occlusion in mice ［J］. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017,22(5):501-506. (in Chinese)

谢跃武, 张芳, 郭岩. 小鼠大脑中动脉栓塞模型脑血流量与梗死体积相关性分析［J］. 中国临床药理学与治疗学, 2017,22(5):501-506.

［10］ Rogaev EI. Small RNAs in human brain development and disorders［J］. Biochemistry (Mosc), 2005, 70(12):1404-1407.

［11］ Min JW. Functions of TRPV1 receptor in rodents model of neonatal hypoxia-ischemia brain damage and the treatment effect of vitexin［D］. Wuhan University, 2016. (in Chinese)

闵加威.TRPV1受体在新生鼠缺血缺氧性脑损伤中的作用及牡荆素干预研究［D］. 武汉大学,2016.

［12］ Liu N, Chen R, Du H, et al. Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells［J］. Cell Mol Immunol, 2009, 6(3):207-213.

［13］ Awooda HA, Sharara GM, Soltani N, et al. Tumor necrosis factor-α and nuclear factor kappa-β expression in rats following transient focal cerebral ischemia reperfusion［J］. Int J Clin Exp Neurol, 2014, 2(2):40-46.

［14］ Miyanohara J, Shirakawa H, Sanpei K, et al. A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice ［J］. Biochem Biophys Res Commun, 2015, 467(3):478-483.

［15］ Keeble J, Russell F, Curtis B, et al. Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation.［J］. Arthritis Rheum, 2005, 52(10):3248-3256.

［16］ Khatibi NH, Jadhav V, Charles S, et al. Capsaicin pre-treatment provides neurovascular protection against neonatal hypoxic-ischemic brain injury in rats.［J］. Acta Neurochir Suppl, 2011, 111:225-230.

［17］ Cao Z, Balasubramanian A, Marrelli SP. Pharmacologically induced hypothermia via TRPV1 channel agonism provides neuroprotection following ischemic stroke when initiated 90 min after reperfusion ［J］. Am J Physiol Regul Integr Comp Physiol, 2014, 306(2):R149-156.